ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In Vivo
- 30 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 213 (8) , 1244-1254
Abstract
Neutrophils can efficiently trigger cytotoxicity toward tumor cells and other target cells upon engagement of the IgA receptor CD89. However, the cell-intrinsic factors that influence the induction of cell death upon exposure to neutrophil effector mechanisms in vivo remain largely unknown. To uncover genetic regulators that influence target cell sensitivity to IgA-induced neutrophil-mediated killing, we used a human CD89 (hCD89) transgenic mouse model in which IgA-mediated killing of Her2-positive CD47-deficient murine target cells is mediated by neutrophils. Using a genome-wide in vivo screening approach, we demonstrate that deletion of the gene encoding inositol-tetrakisphosphate 1 kinase (ITPK1) increases survival of target cells in anti-Her2 IgA-treated mice. Moreover, we show that this effect depends on neutrophil activity and on the ITPK1 kinase domain. Notably, ITPK1 deficiency did not measurably impact survival of IgA-opsonized target cells in in vitro systems, underscoring the importance of in vivo screening systems to uncover physiologically relevant regulators of neutrophil killing.Keywords
This publication has 49 references indexed in Scilit:
- Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strainsCancer Immunology, Immunotherapy, 2023
- A neutrophil response linked to tumor control in immunotherapyCell, 2023
- Therapeutic exploitation of neutrophils to fight cancerSeminars in Immunology, 2021
- Neutrophils Kill Antibody-Opsonized Cancer Cells by TrogoptosisCell Reports, 2018
- MLKL Requires the Inositol Phosphate Code to Execute NecroptosisMolecular Cell, 2018
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch MechanismImmunity, 2013
- IgA EGFR antibodies mediate tumour killing in vivoEMBO Molecular Medicine, 2013
- Enhanced FcαRI‐mediated neutrophil migration towards tumour colonies in the presence of endothelial cellsEuropean Journal of Immunology, 2012
- Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death PathwayCell, 2008
- Tumor cell lysis by activated human neutrophils: Analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1Inflammation, 1991